• Title/Summary/Keyword: Fumarate

Search Result 94, Processing Time 0.027 seconds

Utilization of Multiple Carbon Sources by Plant Cells

  • Lee, Taek-Kyun;Suh, Jung-Bin;Kim, Se-Hee;Lee, Sun-Min;Lee, Woo-Sung
    • Proceedings of the Zoological Society Korea Conference
    • /
    • 1999.10b
    • /
    • pp.11-11
    • /
    • 1999
  • ;It has been reported that suspension-cultured rice cells grown on mixed carbon sources of glucose (GIc) and acetate exhibited diauxic growth in which acetate was the preferred carbon source (Lee and Lee, 1996). Carrot (Daucus carota L.) suspension cells, showing a diauxic growth very similar to that of rice cells, were used to delineate the mechanisms underlying this preferential use of acetate over GIc. Uptakes of both GIc and 3-0-methylglucose (3-0MG), a non-metabolizable GIc analogue, were similarly inhibited when acetate or butylate, weak acids which are capable of transporting protons into the cytosol, were present in the uptake assay mixture containing cells harvested during the GIc-utilizing second growth phase. Inhibition of GIc uptake by these weak acids was similar when equivalent experiments were carried out with isolated plasma membranes. It was further shown that Glc uptake, which requires a proper proton gradient across the plasma membranes, was inhibited during the first growth phase by acetate-mediated alkalization of growth medium and/or simultaneous acidification of cytosol. This study strongly suggests that Glc utilization in plant cells is inhibited by co-presenting carbon source(s) which can alter the proton gradient across the plasma membrane. We further examined diauxic growth in culture containing GIc and malate. Unlike the case in the culture with GIc and acetate, carrot cells used GIc first. Malate was utilized only after Glc is depleted from medium. These results indicate that GIc can be a preferred or less-preferred carbon source depending on the competing carbon source. It was noted that malate was not directly taken up by cells. Instead it was converted extracellularly into fumarate which was subsequently transported into cells. During the malate-growth phase malate uptake was negligible, and fumarate uptake was active and pH-sensitive. It was shown that fumarase released into medium was responsible for the extracellular conversion of malate into fumarate. An immunoblot experiments showed that fumarase antibody raised against Arabidopsis fumarase provided positive signals only in medium in malate culture, not in fumarate or GIc cultures. This study demonstrates the first example in that fumarase, a mitochondria marker enzyme, can be present in places other than mitochondria.ndria.

  • PDF

The Kinetic Parameters of Hafnia alvei Aspartase from pH Studies

  • Kim, Sung-Kun;Choi, Jung-Hoon;Yoon, Moon-Young
    • BMB Reports
    • /
    • v.28 no.3
    • /
    • pp.204-209
    • /
    • 1995
  • The pH dependence of kinetic parameters in the amination direction of the aspartase from Hafnia alvei has been determined. The V/K for fumarate is bell shaped with pK values of 6.4 and 8.7. The maximum velocity for fumarate is also bell shaped with pK values of 7.2 and 9.1. The pH dependence of 1/K, for potassium (competitive inhibitor of ammonia) decreases at low pH with pK 7.6. Together with data [Yoon and Cook (1994) Korean J. Biochem. 27, 1-5] on the deamination direction of the aspartase, these results are consistent with two enzyme groups which are necessary for catalysis. An enzymatic group that must be deprotonated has been identified. Another enzyme group must be protonated for substrate binding. Both the general base and general acid group are in a protonation state opposite that in which they started when aspartate was bound. A proton is abstracted from C-3 of the monoanionic form of L-aspartate by an enzyme general base with, a pK of 6.3~6.6 in the absence and presence of $Mg^{2+}$ Ammonia is then expelled with the assistance of a general acid group giving $NH_{4+}$ as the product.

  • PDF

A Case of Skin Eruption Occurred after Switching Formulation of Quetiapine Fumarate (Quetiapine Fumarate의 제형 변경 후 발생한 피부 발진 1예)

  • Kwon, Yong-Seok;Lim, Se-Won
    • Korean Journal of Biological Psychiatry
    • /
    • v.16 no.4
    • /
    • pp.266-270
    • /
    • 2009
  • Adverse drug reactions are very common in clinical practice, and skin is one of the most frequent organs for adverse drug reactions. We report a case of a 71-year-old male patient who developed skin eruptions after switching formulation of quetiapine immediate release(IR) to quetiapine extended release(XR). He had been taking quetiapine IR(400mg/day) for treatment of manic episode which was developed one year ago. The patient showed great improvement of symptoms after taking quetiapine IR for about one year, thus dosage of medication was reduced to 50mg/day on the average. Unfortunately dose reduction has tended to worsen symptoms, so dose of quetiapine was increased again to 200mg/day with formulation changes to XR. Two days after he took new formulation, erythematous papules were occurred over his anterior neck and ventral side of left wrist. As he stopped quetiapine XR, the skin lesions gradually subsided. And he was successfully treated with readministration of quetiapine IR without any skin lesions.

  • PDF

Enhancement of Succinate Production by Organic Solvents, Detergents, and Vegetable Oils

  • Kang, Kui-Hyun;Ryu, Hwa-Won
    • Journal of Microbiology and Biotechnology
    • /
    • v.9 no.2
    • /
    • pp.191-195
    • /
    • 1999
  • Bioconversion of fumarate to succinate by Enterococcus sp. RKY1 was enhanced when Tween surfactant, organic solvent, and vegetable oil were added to the fermentation medium. The maximum amount of succinate produced was 80.4 g/l after a 24 h incubation when Tween 80 was added to the culture to a final concentration of 0.1 g/l. Triton X-l00 was observed to damage the enzymes and inhibit the formation of succinate. The addition of 10 ml/l acetone increased the production of succinate by 110%. Vegetable oils used were found to be effective for succinate production as well as for the cell growth. Similar productivity increases were obtained with corn oil and Tween 80 plus biotin with the total productivity being 3.6 g/l/h, and 3.5 g/l/h, respectively, which was approximately 25% greater than that of the control. Therefore, these results indicate that com oil can be considered the most appropriate agent for the production of succinate where succinic acid was primarily used in the production of food, medicine, and cosmetics.

  • PDF

Adsorptive Removal of Phosphate Ions from Aqueous Solutions using Zirconium Fumarate

  • Rallapalli, Phani B.S.;Ha, Jeong Hyub
    • Applied Chemistry for Engineering
    • /
    • v.31 no.5
    • /
    • pp.495-501
    • /
    • 2020
  • In this study, zirconium fumarate of metal-organic framework (MOF-801) was solvothermally synthesized at 130 ℃ and characterized through powder X-ray diffraction (PXRD) analyses and porosity measurements from N2 sorption isotherms at 77 K. The ability of MOF-801 to act as an adsorbent for the phosphate removal from aqueous solutions at 25 ℃ was investigated. The phosphate removal efficiency (PRE) obtained by 0.05 g/L adsorbent dose at an initial phosphate concentration of 60 ppm after 3 h was 72.47%, whereas at 5 and 20 ppm, the PRE was determined to be 100% and 89.88%, respectively, after 30 min for the same adsorbent dose. Brunauer-Emmett-Teller (BET) surface area and pore volume of the bare MOF-801 sample were 478.25 ㎡/g and 0.52 ㎤/g, respectively, whereas after phosphate adsorption (at an initial concentration of 60 ppm, 3 h), the BET surface area and pore volume were reduced to 331.66 ㎡/g and 0.39 ㎤/g, respectively. The experimental data of kinetic (measured at initial concentrations of 5, 20 and 60 ppm) and isotherm measurements followed the pseudo-second-order kinetic equation and the Freundlich isotherm model, respectively. This study demonstrates that MOF-801 is a promising material for the removal of phosphate from aqueous solutions.

Multiple Cutaneous Leiomyoma Derived from the Mutation in Fumarate Hydratase Gene: A Case Report (푸마르산 수산화효소 유전자 결함에 따른 다발성 피부 평활근종의 치험례)

  • Kim, Yoong Soo;Tak, Kyoung Seok;Cho, Chung Nam;Chung, Chan Min;Oh, Suk Joon;Lee, Min Jin
    • Archives of Plastic Surgery
    • /
    • v.34 no.5
    • /
    • pp.659-662
    • /
    • 2007
  • Purpose: Multiple skin leiomyoma and uterine myoma bearing autosomal dominant traits are benign smooth muscle tumors which originate in skin or female uterus. Skin leiomyoma occurs after gene mutation originating from arrector pili muscle of hair follicle where its clinical manifestations vary significantly from person to person. Our department hereby reports the histological findings and genetic evaluations of this very rare disease. Methods: A 57-year-old woman presented in our institute with multiple tumors in the left and central parts of her back that started to appear since 19 years ago. The patient was diagnosed as having uterine myoma 15 years ago and underwent hysterectomy. Biopsy has been done on the specimen, and genomic DNA was separated from Fumarate hydratase gene for it to go through PCR amplification. The results of PCR amplification were aligned by sequencer. Results: According to the results of biopsy, tumor cells were spindle-shaped and were aligned in a bundle where there was no dysplasia or mitosis. Moreover, these cells had abundant eosinophilic cytoplasm with elongated nucleus, and benign leiomyoma that showed positive reactions to SMA stain were found. In genetic examination, mutations such as heterozygous single nucleotide substitutions were found in alignments of amplified DNA. Conclusion: Multiple skin leiomyoma and uterine myoma are relatively uncommon diseases that are transmitted through autosomally dominant traits from genetic mutations. When a patient's chief complaint lies upon skin-colored or brown masses that occur in multiples appearing in the trunk or extremities with characteristic clinical symptoms and histological findings, and when the patient's family history is acknowledged such as skin or uterine leiomyoma or renal tumor, necessary genetic examination on multiple skin leiomyoma and uterine myoma could be done, and thereby precise diagnosis could also be made.

Multidetector CT Characteristics of Fumarate Hydratase-Deficient Renal Cell Carcinoma and Papillary Type II Renal Cell Carcinoma

  • Ling Yang;Xue-Ming Li;Ya-Jun Hu;Meng-Ni Zhang;Jin Yao;Bin Song
    • Korean Journal of Radiology
    • /
    • v.22 no.12
    • /
    • pp.1996-2005
    • /
    • 2021
  • Objective: To investigate the multidetector computed tomography (MDCT) features of fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) with germline or somatic mutations, and compare them with those of papillary type II RCC (pRCC type II). Materials and Methods: A total of 24 patients (mean ± standard deviation, 40.4 ± 14.7 years) with pathologically confirmed FH-deficient RCC (15 with germline and 9 with somatic mutations) and 54 patients (58.6 ± 12.6 years) with pRCC type II were enrolled. The MDCT features were retrospectively reviewed and compared between the two entities and mutation subgroups, and were correlated with the clinicopathological findings. Results: All the lesions were unilateral and single. Compared with pRCC type II, FH-deficient RCC was more prevalent among younger patients (40.4 ± 14.7 vs. 58.6 ± 12.6, p < 0.001) and tended to be larger (8.1 ± 4.1 vs. 5.4 ± 3.2, p = 0.002). Cystic solid patterns were more common in FH-deficient RCC (20/24 vs. 16/54, p < 0.001), with 16 of the 20 (80.0%) cystic solid tumors having showed typical polycystic and thin smooth walls and/or septa, with an eccentric solid component. Lymph node (16/24 vs. 16/54, p = 0.003) and distant (11/24 vs. 3/54, p < 0.001) metastases were more frequent in FH-deficient RCC. FH-deficient RCC and pRCC type II showed similar attenuation in the unenhanced phase. The attenuation in the corticomedullary phase (CMP) (76.3% ± 25.0% vs. 60.2 ± 23.6, p = 0.008) and nephrographic phase (NP) (87.7 ± 20.5, vs. 71.2 ± 23.9, p = 0.004), absolute enhancement in CMP (39.0 ± 24.8 vs. 27.1 ± 22.7, p = 0.001) and NP (50.5 ± 20.5 vs. 38.2 ± 21.9, p = 0.001), and relative enhancement ratio to the renal cortex in CMP (0.35 ± 0.26 vs. 0.24 ± 0.19, p = 0.001) and NP (0.43 ± 0.24 vs. 0.29 ± 0.19, p < 0.001) were significantly higher in FH-deficient RCC. No significant difference was found between the FH germline and somatic mutation subgroups in any of the parameters. Conclusion: The MDCT features of FH-deficient RCC were different from those of pRCC type II, whereas there was no statistical difference between the germline and somatic mutation subgroups. A kidney mass with a cystic solid pattern and metastatic tendency, especially in young patients, should be considered for FH-deficient RCC.

푸마르산의 온라인 모니터링을 위한 흐름주입분석 기술 개발

  • Son, Ok-Jae;Lee, Jong-Il
    • 한국생물공학회:학술대회논문집
    • /
    • 2002.04a
    • /
    • pp.136-138
    • /
    • 2002
  • In this work we describe the on-line monitoring technique for the analysis of fumaric acid in biotechnological processes. Fumarase and malate dehydrogenase(MDH) were immobilized on epoxy carrier and integrated into a FIA system. The effects of carrier buffer flow rate, pH, reaction temperature on the immobilized fumarase/MDH were investigated for the development of a fumarate-FIA system. Furthermore the effects of substrates, salts and metabolites dissolved in the sample on the activity of the immobilized enzyme were investigated.

  • PDF

The Photoaddition Reaction of 1,4-Diphenyl-1,3-butadiyne with 5-Fluorouracil

  • Shim, Sang-Chul;Lee, Tae-Suk;Kim, Sung-Sik
    • Bulletin of the Korean Chemical Society
    • /
    • v.7 no.3
    • /
    • pp.228-230
    • /
    • 1986
  • Diacetylene compound, 1,4-diphenyl-1,3-butadiyne, was photolyzed with 5-fluorouracil as a model reaction of the phototoxic conjugated poly-ynes with DNA or RNA and obtained a [2 + 2] photocycloadduct. The structure of the photoadduct was determined by spectral methods and compared with the [2 + 2] photoadducts of 1,4-diphenyl-1,3-butadiyne with tetramethylethylene and dimethyl fumarate.